chevron_leftBack
As of 5 June 2026, Voyageur Pharmaceuticals Ltd. has a market cap of $13.56M USD, ranking #39620 globally and #1500 in Canada.
It ranks #4505 in the Basic Materials sector, and #218 in the Agricultural Inputs industry.
Key Stats
Market Cap
$13.56MUSD
18.84M CAD
Enterprise Value
$13.53MUSD
18.81M CAD
Revenue (TTM)
$22.27KUSD
30.96K CAD
EBITDA (TTM)
-$2.02MUSD
-2.81M CAD
Net Income (TTM)
-$2.4MUSD
-3.34M CAD
PS Ratio
608.7
PB Ratio
28.5
Company Profile
Country (HQ)
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Brent Willis
open_in_new
Website
voyageurpharmaceuticals.ca
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -4.8% | 21% | -17% | -33% | -33% | -46% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
VM
Voyageur Pharmaceuticals Ltd
ISIN: CA92918C1014
Shares Out.:
Shares Outstanding:
179.476M1
Shares Float:
163.197M2
|
0.1000 CAD | |
|
VM
Voyageur Pharmaceuticals Ltd
ISIN: CA92918C1014
|
0.0950 CAD | |
|
VYYRF
Voyageur Pharmaceuticals Ltd
ISIN: CA92918C1014
Shares Out.:
Shares Outstanding:
168.262M1
Shares Float:
152.52M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.1285 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer Aktiengesellschaft for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSX: NTR
|
$34.53B
255K%
48.0B CAD
|
15.6
|
|
TSXV: LI
|
$108.53M
700%
150.84M CAD
|
-
|
|
TSXV: RCK
|
$82.88M
511%
115.2M CAD
|
-
|
|
CSE: ARS
|
$77.36M
471%
107.52M CAD
|
-
|
|
TSXV: CRE
|
$69.28M
411%
96.3M CAD
|
-
|
|
TSXV: GSP
|
$56.35M
316%
78.32M CAD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 000792
|
$30.88B
228K%
209.02B CNY
|
20.3
|
|
NYSE: CF
|
$19.48B
144K%
|
13.6
|
|
TADAWUL: 2020
|
$18.35B
135K%
68.93B SAR
|
15.1
|
|
OSL: YAR
|
$14.65B
108K%
136.53B NOK
|
10.0
|
|
MOEX: PHOR
|
$10.89B
80K%
803.16B RUB
|
8.9
|
|
MOEX: AKRN
|
$8.9B
66K%
656.12B RUB
|
16.9
|
chevron_leftBack